The Texas Closed Formulary is constructed such that any compounded medication containing all “Y” ingredients (contrasted with “N” drugs) will process as presumptively approved and thus be subject only to retrospective review. The exception is a non-FDA approved or experimental medication, which is subject to a preauthorization process.
As a result, since 2011 the cost and utilization of compounded medications in Texas has increased, sparking concern among stakeholders and increasing disputes between pharmacies and payers.
In 2015, the Texas Division of Worker...
Comments